- Home
- IMRN vs IDAI Comparison
IMRN vs IDAI Comparison
Compare IMRN & IDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMRN
- IDAI
- Stock Information
- Founded
- IMRN 1994
- IDAI 2016
- Country
- IMRN Australia
- IDAI United States
- Employees
- IMRN N/A
- IDAI N/A
- Industry
- IMRN Biotechnology: Pharmaceutical Preparations
- IDAI Computer Software: Prepackaged Software
- Sector
- IMRN Health Care
- IDAI Technology
- Exchange
- IMRN Nasdaq
- IDAI Nasdaq
- Market Cap
- IMRN 9.2M
- IDAI 7.7M
- IPO Year
- IMRN N/A
- IDAI N/A
- Fundamental
- Price
- IMRN $1.86
- IDAI $2.98
- Analyst Decision
- IMRN Strong Buy
- IDAI
- Analyst Count
- IMRN 1
- IDAI 0
- Target Price
- IMRN $5.00
- IDAI N/A
- AVG Volume (30 Days)
- IMRN 55.1K
- IDAI 23.5K
- Earning Date
- IMRN 08-29-2025
- IDAI 08-14-2025
- Dividend Yield
- IMRN N/A
- IDAI N/A
- EPS Growth
- IMRN N/A
- IDAI N/A
- EPS
- IMRN N/A
- IDAI N/A
- Revenue
- IMRN $4,777,422.00
- IDAI $3,366,415.00
- Revenue This Year
- IMRN N/A
- IDAI $25.13
- Revenue Next Year
- IMRN N/A
- IDAI $48.09
- P/E Ratio
- IMRN N/A
- IDAI N/A
- Revenue Growth
- IMRN 48.63
- IDAI N/A
- 52 Week Low
- IMRN $1.50
- IDAI $1.43
- 52 Week High
- IMRN $2.87
- IDAI $18.75
- Technical
- Relative Strength Index (RSI)
- IMRN 56.87
- IDAI 54.65
- Support Level
- IMRN $1.73
- IDAI $2.71
- Resistance Level
- IMRN $1.89
- IDAI $3.08
- Average True Range (ATR)
- IMRN 0.10
- IDAI 0.17
- MACD
- IMRN 0.01
- IDAI 0.01
- Stochastic Oscillator
- IMRN 76.77
- IDAI 73.96
About IMRN Immuron Limited
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.
About IDAI T Stamp Inc.
T Stamp Inc develops and markets identity authentication software solutions for enterprise partners and peer-to-peer markets. The company is engaged in developing proprietary artificial intelligence-powered solutions; researching and leveraging biometric science, cryptography, and data mining to deliver insightful identity & trust predictions while identifying and defending against fraudulent identity attacks, protecting sensitive user information, and extending the reach of digital services through accessibility. The artificial intelligence-powered solutions segment generates revenue principally from software licenses, professional services, and recurring Software-as-a-Service ("SaaS") revenue.